Thus, the addition of a sugar group to the C1‐hydroxyl group of ceramide by glucosylceramide synthase (ceramide glucosyltransferase; GlcT) can add another final layer of complication to cancer cell signaling. This evidence concerns the gene UGCG and cancer.